B

Halozyme Therapeutics, Inc. HALO

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue 492.97M 481.00M 376.71M 451.77M 354.26M
Total Other Revenue -- -- -- -- --
Total Revenue 492.97M 481.00M 376.71M 451.77M 354.26M
Cost of Revenue 110.25M 106.84M 104.80M 110.67M 72.49M
Gross Profit 382.72M 374.16M 271.91M 341.10M 281.77M
SG&A Expenses 58.24M 57.00M 57.88M 63.33M 46.09M
Depreciation & Amortization 29.51M 29.51M 29.51M 23.38M 17.76M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 198.01M 193.35M 192.19M 197.37M 136.34M
Operating Income 294.97M 287.65M 184.52M 254.40M 217.92M
Income Before Tax 290.63M 284.90M 180.33M -100.85M 218.96M
Income Tax Expenses 43.58M 54.99M 30.28M 40.74M 43.73M
Earnings from Continuing Operations 247.05M 229.91M 150.05M -141.59M 175.23M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 247.05M 229.91M 150.05M -141.59M 175.23M
EBIT 294.97M 287.65M 184.52M 254.40M 217.92M
EBITDA 326.57M 319.12M 215.65M 279.08M 236.84M
EPS Basic 2.17 1.96 1.27 -1.20 1.49
Normalized Basic EPS 1.60 1.52 0.95 1.34 1.17
EPS Diluted 2.01 1.90 1.22 -1.20 1.43
Normalized Diluted EPS 1.48 1.47 0.92 1.34 1.12
Average Basic Shares Outstanding 113.80M 117.27M 118.14M 117.67M 117.22M
Average Diluted Shares Outstanding 122.61M 121.22M 122.88M 117.67M 122.33M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --